We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$31.3B
AUM Growth
+$1.67B
Cap. Flow
+$1.83B
Cap. Flow %
5.84%
Top 10 Hldgs %
37.77%
Holding
1,441
New
112
Increased
695
Reduced
355
Closed
81

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$698M
2
NFLX icon
Netflix
NFLX
+$243M
3
VTR icon
Ventas
VTR
+$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Sector Composition

Rank Sector Weight
1 Technology 30.75%
2 Real Estate 25.79%
3 Communication Services 11.7%
4 Consumer Discretionary 7.26%
5 Financials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQT icon
1176
Arcutis Biotherapeutics
ARQT
$3.5B
$10K ﹤0.01%
358
-1
-0.3% -$26
CGON icon
1177
CG Oncology
CGON
$6.16B
$10K ﹤0.01%
239
+5
+2% +$207
TVTX icon
1178
Travere Therapeutics
TVTX
$5.12B
$10K ﹤0.01%
258
VCYT icon
1179
Veracyte
VCYT
$4.46B
$10K ﹤0.01%
226
-40
-15% -$1.61K
XENE icon
1180
Xenon Pharmaceuticals
XENE
$6.23B
$10K ﹤0.01%
229
-23
-9% -$966
GRAL
1181
GRAIL Inc
GRAL
$2.67B
$10K ﹤0.01%
116
-13
-10% -$1.12K
APLS
1182
DELISTED
Apellis Pharmaceuticals
APLS
$9K ﹤0.01%
369
-60
-14% -$1.41K
EWTX icon
1183
Edgewise Therapeutics
EWTX
$4.29B
$9K ﹤0.01%
344
IRON icon
1184
Disc Medicine
IRON
$2.79B
$9K ﹤0.01%
113
MLYS icon
1185
Mineralys Therapeutics
MLYS
$2.35B
$9K ﹤0.01%
235
+36
+18% +$1.44K
OCUL icon
1186
Ocular Therapeutix
OCUL
$1.83B
$9K ﹤0.01%
710
+117
+20% +$1.42K
SUPN icon
1187
Supernus Pharmaceuticals
SUPN
$2.73B
$9K ﹤0.01%
176
VERA icon
1188
Vera Therapeutics
VERA
$2.31B
$9K ﹤0.01%
183
+1
+0.5% +$36
WVE icon
1189
Wave Life Sciences
WVE
$1.12B
$9K ﹤0.01%
503
BEAM icon
1190
Beam Therapeutics
BEAM
$2.65B
$8K ﹤0.01%
302
-3,153
-91% -$80.4K
DNLI icon
1191
Denali Therapeutics
DNLI
$3.78B
$8K ﹤0.01%
475
DYN icon
1192
Dyne Therapeutics
DYN
$4.25B
$8K ﹤0.01%
424
+53
+14% +$1K
SYRE icon
1193
Spyre Therapeutics
SYRE
$8.36B
$8K ﹤0.01%
258
+52
+25% +$1.36K
VGSH icon
1194
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$8K ﹤0.01%
135
+94
+229% +$5.53K
VWOB icon
1195
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
$8K ﹤0.01%
117
-111
-49% -$7.49K
XLK icon
1196
State Street Technology Select Sector SPDR ETF
XLK
$110B
$8K ﹤0.01%
58
ADPT icon
1197
Adaptive Biotechnologies
ADPT
$3.53B
$7K ﹤0.01%
430
-100
-19% -$1.63K
AUPH icon
1198
Aurinia Pharmaceuticals
AUPH
$1.92B
$7K ﹤0.01%
413
CNTA
1199
DELISTED
Centessa Pharmaceuticals
CNTA
$7K ﹤0.01%
294
EWW icon
1200
iShares MSCI Mexico ETF
EWW
$1.89B
$7K ﹤0.01%
100

Similar funds

Daiwa Securities Group's Q4 2025 Portfolio in Review

As of Q4 2025, Daiwa Securities Group held 1,441 positions worth $31.3B, up 5.6% from $29.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group deployed $1.83B of net new capital in Q4 2025, opening 112 new positions and adding to 695 existing holdings. Its largest new stake was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $542M trimmed.

  • Daiwa Securities Group's largest Q4 2025 buy was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.
  • Daiwa Securities Group added most to Palantir in Q4 2025, an estimated $698M increase.
  • Daiwa Securities Group's biggest Q4 2025 reduction was ServiceNow, cutting an estimated $542M.
  • Daiwa Securities Group fully exited Eagle Materials in Q4 2025, selling an estimated $12.8M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $31.3B portfolio in Q4 2025.
  • Daiwa Securities Group opened 112 new positions and closed 81 in Q4 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $31.3B.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.